Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Treasury Shares (2016 - 2025)

Angiodynamics (ANGO) has disclosed Treasury Shares for 14 consecutive years, with $7.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares changed 0.0% year-over-year to $7.4 million, compared with a TTM value of $7.4 million through Nov 2025, changed 0.0%, and an annual FY2025 reading of $7.4 million, up 29.17% over the prior year.
  • Treasury Shares was $613847.0 for Q4 2025 at Angiodynamics, roughly flat from $613847.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $613.8 million in Q4 2024 and bottomed at $370000.0 in Q2 2021.
  • Average Treasury Shares over 5 years is $219.5 million, with a median of $370.0 million recorded in 2021.
  • The sharpest move saw Treasury Shares changed 0.0% in 2021, then rose 29.17% in 2024.
  • Year by year, Treasury Shares stood at $5.7 million in 2021, then changed by 0.0% to $5.7 million in 2022, then changed by 0.0% to $5.7 million in 2023, then rose by 29.17% to $7.4 million in 2024, then changed by 0.0% to $7.4 million in 2025.
  • Business Quant data shows Treasury Shares for ANGO at $7.4 million in Q4 2025, $7.4 million in Q3 2025, and $7.4 million in Q2 2025.